Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease

Both genetic and non-genetic factors are important in the pathophysiology of non-alcoholic fatty liver disease (NAFLD). The aim of our study was to identify novel metabolites and pathways associated with NAFLD by including both genetic and non-genetic factors in statistical analyses. We genotyped si...

Full description

Bibliographic Details
Main Authors: Lilian Fernandes Silva, Jagadish Vangipurapu, Anniina Oravilahti, Ville Männistö, Markku Laakso
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/2/267
_version_ 1797619304819064832
author Lilian Fernandes Silva
Jagadish Vangipurapu
Anniina Oravilahti
Ville Männistö
Markku Laakso
author_facet Lilian Fernandes Silva
Jagadish Vangipurapu
Anniina Oravilahti
Ville Männistö
Markku Laakso
author_sort Lilian Fernandes Silva
collection DOAJ
description Both genetic and non-genetic factors are important in the pathophysiology of non-alcoholic fatty liver disease (NAFLD). The aim of our study was to identify novel metabolites and pathways associated with NAFLD by including both genetic and non-genetic factors in statistical analyses. We genotyped six genetic variants in the <i>PNPLA3, TM6SF2, MBOAT7, GCKR</i>, <i>PPP1R3B</i>, and <i>HSD17B13</i> genes reported to be associated with NAFLD. Non-targeted metabolomic profiling was performed from plasma samples. We applied a previously validated fatty liver index to identify participants with NAFLD. First, we associated the six genetic variants with 1098 metabolites in 2 339 men without NAFLD to determine the effects of the genetic variants on metabolites, and then in 2 535 men with NAFLD to determine the joint effects of genetic variants and non-genetic factors on metabolites. We identified several novel metabolites and metabolic pathways, especially for <i>PNPLA3, GCKR,</i> and <i>PPP1R38</i> variants relevant to the pathophysiology of NAFLD. Importantly, we showed that each genetic variant for NAFLD had a specific metabolite signature. The plasma metabolite signature was unique for each genetic variant, suggesting that several metabolites and different pathways are involved in the risk of NAFLD. The FLI index reliably identifies metabolites for NAFLD in large population-based studies.
first_indexed 2024-03-11T08:26:15Z
format Article
id doaj.art-6c29663d64fd4b85a8d17ad67a974c94
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T08:26:15Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-6c29663d64fd4b85a8d17ad67a974c942023-11-16T22:05:13ZengMDPI AGMetabolites2218-19892023-02-0113226710.3390/metabo13020267Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver DiseaseLilian Fernandes Silva0Jagadish Vangipurapu1Anniina Oravilahti2Ville Männistö3Markku Laakso4Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, FinlandBoth genetic and non-genetic factors are important in the pathophysiology of non-alcoholic fatty liver disease (NAFLD). The aim of our study was to identify novel metabolites and pathways associated with NAFLD by including both genetic and non-genetic factors in statistical analyses. We genotyped six genetic variants in the <i>PNPLA3, TM6SF2, MBOAT7, GCKR</i>, <i>PPP1R3B</i>, and <i>HSD17B13</i> genes reported to be associated with NAFLD. Non-targeted metabolomic profiling was performed from plasma samples. We applied a previously validated fatty liver index to identify participants with NAFLD. First, we associated the six genetic variants with 1098 metabolites in 2 339 men without NAFLD to determine the effects of the genetic variants on metabolites, and then in 2 535 men with NAFLD to determine the joint effects of genetic variants and non-genetic factors on metabolites. We identified several novel metabolites and metabolic pathways, especially for <i>PNPLA3, GCKR,</i> and <i>PPP1R38</i> variants relevant to the pathophysiology of NAFLD. Importantly, we showed that each genetic variant for NAFLD had a specific metabolite signature. The plasma metabolite signature was unique for each genetic variant, suggesting that several metabolites and different pathways are involved in the risk of NAFLD. The FLI index reliably identifies metabolites for NAFLD in large population-based studies.https://www.mdpi.com/2218-1989/13/2/267non-alcoholic fatty liver diseasegenetic variantsmetabolomics
spellingShingle Lilian Fernandes Silva
Jagadish Vangipurapu
Anniina Oravilahti
Ville Männistö
Markku Laakso
Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease
Metabolites
non-alcoholic fatty liver disease
genetic variants
metabolomics
title Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease
title_full Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease
title_fullStr Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease
title_full_unstemmed Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease
title_short Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease
title_sort plasma metabolite signatures in male carriers of genetic variants associated with non alcoholic fatty liver disease
topic non-alcoholic fatty liver disease
genetic variants
metabolomics
url https://www.mdpi.com/2218-1989/13/2/267
work_keys_str_mv AT lilianfernandessilva plasmametabolitesignaturesinmalecarriersofgeneticvariantsassociatedwithnonalcoholicfattyliverdisease
AT jagadishvangipurapu plasmametabolitesignaturesinmalecarriersofgeneticvariantsassociatedwithnonalcoholicfattyliverdisease
AT anniinaoravilahti plasmametabolitesignaturesinmalecarriersofgeneticvariantsassociatedwithnonalcoholicfattyliverdisease
AT villemannisto plasmametabolitesignaturesinmalecarriersofgeneticvariantsassociatedwithnonalcoholicfattyliverdisease
AT markkulaakso plasmametabolitesignaturesinmalecarriersofgeneticvariantsassociatedwithnonalcoholicfattyliverdisease